Stock Price Forecast

April 19, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Akers Biosciences Inc chart...

About the Company

We do not have any company description for Akers Biosciences Inc at the moment.

Please visit http://www.akersbio.com for more information about the company.

CEO

Howard Yeaton

Exchange

NASDAQ CAPITAL MARKET

Website

http://www.akersbio.com

$2M

Total Revenue

12

Employees

$20M

Market Capitalization

-0.99

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AKER News

Betsy Akers reveals $35M Tuxedo Park mansion as her priciest listing yet

2d ago, source: Rough Draft Atlanta on MSN

Betsy Akers recently secured the No. 3 volume spot at the Atlanta REALTORS® Association Top Producers gala, a testament to her remarkable career in the real estate industry. Grateful for her clients’ ...

INZY Inozyme Pharma, Inc.

21h ago, source: Seeking Alpha

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases.

Kaleido Biosciences Inc KLDO

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Pacira BioSciences Inc.

2d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Q4 2023 Coherus BioSciences Inc Earnings Call

14d ago, source: Yahoo Finance

Jami Taylor; VP of IR; Coherus BioSciences, Inc. Dennis Lanfear; President and CEO; Coherus BioSciences, Inc. Paul Reider; Chief Commercial Officer; Coherus ...

Hudson Bay Capital Management LP's Net Worth

22d ago, source: Benzinga.com

Who is Hudson Bay Capital Management LP? Hudson Bay Capital Management LP has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include ...

Bright Minds Biosciences Inc.

2mon ago, source: CNN

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31 ...

Forte Biosciences Inc Ordinary Shares FBRX

2d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Castle Biosciences, Inc. (NASDAQ:CSTL): Are Analysts Optimistic?

27d ago, source: Yahoo Finance

With the business potentially at an important milestone, we thought we'd take a closer look at Castle Biosciences, Inc.'s (NASDAQ:CSTL) future prospects. Castle Biosciences, Inc., a commercial ...

Cam Akers: Not tendered by Vikings

14d ago, source:

Akers (Achilles) wasn't tendered by the Vikings, making him an unrestricted free agent, Tom Pelissero of NFL Network reports.

Cam Akers Becomes A Free Agent

14d ago, source: RotoBaller on MSN

The Minnesota Vikings declined to offer a restricted free-agent tender to running back Cam Akers (Achilles), meaning he is a free agent and can negotiate freely with any team. The former second-round ...

PCRX Pacira BioSciences, Inc.

8d ago, source: Seeking Alpha

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...